Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
Universidad Autónoma de Madrid, 28049 Madrid, Spain; Immunology Unit from Hospital Universitario de La Princesa and Instituto de Investigación Sanitaria Princesa, 28006 Madrid, Spain.
Cell Rep Med. 2023 Oct 17;4(10):101202. doi: 10.1016/j.xcrm.2023.101202. Epub 2023 Sep 22.
Human immunodeficiency virus (HIV) infection induces immunological dysfunction, which limits the elimination of HIV-infected cells during treated infection. Identifying and targeting dysfunctional immune cells might help accelerate the purging of the persistent viral reservoir. Here, we show that chronic HIV infection increases natural killer (NK) cell populations expressing the negative immune regulator KLRG1, both in peripheral blood and lymph nodes. Antiretroviral treatment (ART) does not reestablish these functionally impaired NK populations, and the expression of KLRG1 correlates with active HIV transcription. Targeting KLRG1 with specific antibodies significantly restores the capacity of NK cells to kill HIV-infected cells, reactivates latent HIV present in CD4 T cells co-expressing KLRG1, and reduces the intact HIV genomes in samples from ART-treated individuals. Our data support the potential use of immunotherapy against the KLRG1 receptor to impact the viral reservoir during HIV persistence.
人类免疫缺陷病毒(HIV)感染会诱导免疫功能障碍,从而限制治疗感染期间对 HIV 感染细胞的清除。鉴定和靶向功能失调的免疫细胞可能有助于加速清除持续存在的病毒库。在这里,我们发现慢性 HIV 感染会增加表达负免疫调节剂 KLRG1 的自然杀伤(NK)细胞群体,无论是在外周血还是淋巴结中。抗逆转录病毒治疗(ART)并不能重建这些功能受损的 NK 细胞群体,并且 KLRG1 的表达与活跃的 HIV 转录相关。用特异性抗体靶向 KLRG1 可显著恢复 NK 细胞杀伤 HIV 感染细胞的能力,重新激活共表达 KLRG1 的 CD4 T 细胞中潜伏的 HIV,并减少 ART 治疗个体样本中完整的 HIV 基因组。我们的数据支持使用针对 KLRG1 受体的免疫疗法在 HIV 持续存在期间影响病毒库的潜力。
Emerg Microbes Infect. 2020-12
Eur J Immunol. 2019-3-25
Front Immunol. 2022
PLoS One. 2019-4-25
Cancer Immunol Immunother. 2025-5-15
Front Med (Lausanne). 2025-4-15
Biomedicines. 2024-7-25
Cell Commun Signal. 2024-6-19
Clin Exp Med. 2024-5-2
Cell Host Microbe. 2023-1-11
Front Immunol. 2022
Nat Commun. 2022-1-10